SM Herrmann, J Ringel, JG Wang, JA … - Diabetes, 2002 - Am Diabetes Assoc The Pro12Ala polymorphism of the gene encoding the peroxisome
proliferator-activated receptor (PPAR)-γ2 has recently been shown to be
associated with type 2 diabetes. In the present analysis, we investigated ... Cited by 48 - Related articles - BL Direct - All 6 versions
ML Caramori, LH Canani, LA Costa, JL Gross - Diabetes, 2003 - Am Diabetes Assoc The peroxisome proliferator-activated receptor γ2 (PPARγ2) Pro12Ala
polymorphism has been associated with a decreased risk of type 2 diabetes and a
lower albumin excretion rate (AER) in patients with established diabetes. ... Cited by 44 - Related articles - BL Direct - All 4 versions
RL Pollex, M Mamakeesick, B Zinman, SB … - Journal of Diabetes and Its Complications, 2007 - Elsevier One putative determinant of diabetic nephropathy is the Pro12Ala (P12A)
polymorphism in the gene encoding peroxisome proliferator-activated receptor γ
(PPARγ). Previous research has found a “protective” role for the A12 ... Cited by 15 - Related articles - All 9 versions
A Jorsal, L Tarnow, M Lajer, J Ek, T Hansen, … - Molecular genetics and metabolism, 2008 - Elsevier The Pro12Ala polymorphism in the peroxisome proliferator-activated receptor-γ2
gene is suggested to associate with diabetic nephropathy and cardiovascular
disease in type 2 diabetes. The aim of this study was to investigate the ... Cited by 6 - Related articles - All 3 versions
LH Canani, DPK Ng, A Smiles, JJ Rogus, JH … - Diabetes, 2002 - Am Diabetes Assoc A polymorphism in the ecto-nucleotide pyrophosphatase/phosphodiesterase 1 gene
(ENPP1) (previously known as PC-1), resulting in an amino acid change from
lysine to glutamine at codon 121 (K121Q), is associated with insulin ... Cited by 42 - Related articles - BL Direct - All 4 versions
- ►oxfordjournals.org SD Cosmo, G Miscio, L Zucaro, M Margaglione, A … - Nephrology Dialysis Transplantation, 2002 - ERA-EDTA Background. The DD genotype of the ACE gene predisposes to faster diabetic
nephropathy (DN) progression but its role in DN development is more
controversial. We reported previously, in type 1 diabetic patients, an ... Cited by 20 - Related articles - BL Direct - All 4 versions
- ►oxfordjournals.org P Jacobsen, N Grarup, L Tarnow, HH Parving … - Nephrology Dialysis Transplantation, 2002 - ERA-EDTA Results. Patients carrying the Q allele had a mean rate of decline in GFR during
follow-up of 3.6 ml/min per year (SE 0.4) compared with 4.0 ml/min per year (SE
0.3) in patients with the KK genotype. Other risk factors for progression ... Cited by 16 - Related articles - BL Direct - All 4 versions
MT Malecki, K Cyganek, B Mirkiewicz- … - Diabetes Research and Clinical Practice, 2008 - Elsevier We examined 238 T2DM subjects without DR (NDR) and 121 with DR (mean diabetes
duration: 9.1 ± 6.8 and 15.1 ± 7.7, respectively). The subjects were genotyped
for four markers: Pro12Ala of PPARγ, SNP43 of calpain 10, rs3787345 and ... Cited by 5 - Related articles - All 12 versions
D Paltoo, K Woodson, P Taylor, D Albanes, J … - Cancer Letters, 2003 - Elsevier The nuclear hormone receptor peroxisome proliferator-activated receptor-gamma
(PPAR-γ) may play a role in prostate carcinogenesis. We examined the
association between the PPAR-γ Pro12Ala polymorphism and prostate cancer ... Cited by 33 - Related articles - All 8 versions
Y Bossé, SJ Weisnagel, C Bouchard, JP … - Journal of Human Genetics, 2003 - Springer Page 1. ORIGINAL ARTICLE Yohan Bossé Æ S. John Weisnagel Æ Claude Bouchard
Jean-Pierre Després Æ Louis Pérusse Æ Marie-Claude Vohl ... Cited by 9 - Related articles - BL Direct - All 7 versions
